291 related articles for article (PubMed ID: 32167932)
1. APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cao L; Cheng H; Jiang Q; Li H; Wu Z
Aging (Albany NY); 2020 Mar; 12(5):4573-4591. PubMed ID: 32167932
[TBL] [Abstract][Full Text] [Related]
2. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; MartÃnez-Chantar ML; Mato JM; Lu SC
Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma.
Huang X; Wang H; Xu F; Lv L; Wang R; Jiang B; Liu T; Hu H; Jiang Y
Aging (Albany NY); 2022 Jan; 14(2):747-769. PubMed ID: 35073517
[TBL] [Abstract][Full Text] [Related]
4. Up-Regulation of SLC26A6 in Hepatocellular Carcinoma and Its Diagnostic and Prognostic Significance.
Zhu Y; Huang Y; Chen L; Guo L; Wang L; Li M; Liang Y
Crit Rev Eukaryot Gene Expr; 2021; 31(5):79-94. PubMed ID: 34591393
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
8.
Sun Z; Chen G; Wang L; Sang Q; Xu G; Zhang N
Aging (Albany NY); 2022 Oct; 14(19):7959-7971. PubMed ID: 36205565
[TBL] [Abstract][Full Text] [Related]
9. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
Liu B; Zhang J; Huang C; Liu H
PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
[TBL] [Abstract][Full Text] [Related]
10. Angiogenic Factor with G Patch and FHA Domains 1 (AGGF1) Acts as Diagnostic Biomarker and Adverse Prognostic Factor of Hepatocellular Carcinoma (HCC): Evidence from Bioinformatic Analysis.
Wang W; Zhu G; Lai S; Guo Y; Yin X; Chen D; Wen L
Med Sci Monit; 2020 Feb; 26():e919896. PubMed ID: 32090983
[TBL] [Abstract][Full Text] [Related]
11. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
12. Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.
Su WL; Chuang SC; Wang YC; Chen LA; Huang JW; Chang WT; Wang SN; Lee KT; Lin CS; Kuo KK
Cancer Biomark; 2020; 28(3):341-350. PubMed ID: 32390596
[TBL] [Abstract][Full Text] [Related]
13. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
14. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma.
Chen J; Gao G; Zhang Y; Dai P; Huang Y
BMC Cancer; 2023 Sep; 23(1):899. PubMed ID: 37743471
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and Clinical Significance of Jagged-1-activated Notch Signaling by APEX1 in Colorectal Cancer.
Kim HB; Lim HJ; Lee HJ; Park JH; Park SG
Anticancer Res; 2019 Nov; 39(11):6097-6105. PubMed ID: 31704837
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
Wang H; Xu F; Yang F; Lv L; Jiang Y
Sci Rep; 2021 Jul; 11(1):14611. PubMed ID: 34272452
[TBL] [Abstract][Full Text] [Related]
18. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of APEX1 p.Asp148Glu and XRCC1 p.Gln399Arg with the susceptibility of hepatocellular carcinoma.
Saad AM; Abdel-Megied AES; Elbaz RA; Hassab El-Nabi SE; Elshazli RM
J Med Virol; 2021 Nov; 93(11):6278-6291. PubMed ID: 34289138
[TBL] [Abstract][Full Text] [Related]
20. High nuclear expression of APE1 correlates with unfavorable prognosis and promotes tumor growth in hepatocellular carcinoma.
Lu X; Zhao H; Yuan H; Chu Y; Zhu X
J Mol Histol; 2021 Apr; 52(2):219-231. PubMed ID: 33392892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
